In the Monday call I heard Dr. NP specifically say that someone (Gilead?) wanted to do a combo trial with remdesivir and leronlimab, but that we'll do that later.
Looking for the exact wording.
Maybe that means that Gilead walked away from CytoDyn and is finding an alternative MAB.